Food Recall Warning (Allergen) - Cavendish Farms brand Classic Hash Brown Patties and no name brand Potato Patties recalled due to undeclared wheat and barley
OTTAWA, ON, March 12, 2022 /CNW/ -
Summary
Brand(s): Cavendish Farms, no name
Products: Classic Hash Brown Patties, Potato Patties
Companies: Cavendish Farms Corporation
Issue: Food ? Allergen ? Gluten, Wheat
Category: Other
What to do: If you have an allergy to wheat or have celiac disease or other gluten-related disorders, do not consume the recalled products
Audience: General public
Hazard classification: Class 1
Affected products
Brand
Product
Size
UPC
Codes
Cavendish Farms
Classic Hash Brown Patties
1.2 kg
0 56210 26106 9
BB/MA 2024 FE 14
no name
Potato Patties
1.2 kg
0 60383 01048 5
BB/MA 2023 AU 04 LB
BB/MA 2023 AU 05 LB
BB/MA 2023 AU 06 LB
Issue
Cavendish Farms Corporation is recalling Cavendish Farms brand Classic Hash Brown Patties and no name brand Potato Patties from the marketplace because they contain wheat which is not declared on the label.
The recalled products have been sold in British Columbia, Alberta, and Manitoba and may have been distributed in other provinces and territories.
What you should do
Check to see if you have the recalled products in your home
If you have an allergy to wheat or have celiac disease or other gluten-related disorders, do not consume the recalled products as they may cause a serious or life-threatening reaction
Recalled products should be thrown out or returned to the location where they were purchased
This recall was triggered by the Canadian Food Inspection Agency's inspection activities.
There have been no reported reactions associated with the consumption of these products.
What is being done
The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.
The CFIA is verifying that industry is removing the recalled products from the marketplace.
Parallel Bio, a biotech company using the immune system to cure disease, today announced the release of its Clinical Trial in a Dish for studying the efficacy and safety of new immunotherapies using human models at the earliest stages of drug...
In response to the overwhelming demand for health care in Gaza, the Canadian Red Cross, in collaboration with the International Committee of the Red Cross (ICRC), the Norwegian Red Cross, and nine other National Red Cross Societies, has opened a...
By meeting key standards of board oversight, finances, results reporting and fundraising appeals, Hope for Ukraine achieved accreditation by the BBB Wise Giving Alliance. This accreditation signifies that Hope for Ukraine is deserving of donor trust...
PAREMINA, the anti-aging pioneer from Switzerland, celebrates its successful debut at BeautyWorld Tokyo 2024. The event marks a significant milestone for PAREMINA as it introduces its novel concept of longevity, "BeautySpan" to the Asian market....
Drug Screening Market in terms of revenue was estimated to be worth $9.1 billion in 2024 and is poised to reach $19.5 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029 according to a new report by MarketsandMarketstm.
Factors such as...
Allied Market Research published a report, titled, "Peripheral Artery Disease Market by Product Type (Devices and Drugs), and End User (Hospitals and Specialty Clinics): Global Opportunity Analysis and Industry Forecast, 2024-2035". According to the...